TELA Bio, Inc. Interest Expense
TELA Bio, Inc. (TELA) reported Interest Expense of $1.33 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-10
- TELA Bio, Inc. interest expense for the quarter ending 2024-03-31 was $1.33M, a 6.90% increase year-over-year.
- TELA Bio, Inc. interest expense for the quarter ending 2023-12-31 was $1.34M, a 14.57% increase year-over-year.
- TELA Bio, Inc. interest expense for the quarter ending 2023-09-30 was $1.33M, a 29.26% increase year-over-year.
- TELA Bio, Inc. interest expense for the quarter ending 2023-06-30 was $1.30M, a 38.97% increase year-over-year.
- TELA Bio, Inc. interest expense for fiscal 2023 was $5.22M, a 28.93% increase from fiscal 2022.
- TELA Bio, Inc. interest expense for fiscal 2022 was $4.05M, a 12.62% increase from fiscal 2021.
- TELA Bio, Inc. interest expense for fiscal 2021 was $3.60M, a 0.93% increase from fiscal 2020.
- TELA Bio, Inc. interest expense for fiscal 2020 was $3.56M, a 1.25% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.33M 10-Q · filed 2024-05-10 | $2.68M derived: sum of 2 quarters · filed 2024-05-10 | $4.01M derived: sum of 3 quarters · filed 2024-05-10 | $5.31M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $2.68M derived: sum of 2 quarters · filed 2024-03-22 | $3.98M derived: sum of 3 quarters · filed 2024-03-22 | $5.22M 10-K · filed 2024-03-22 |
| 2023-09-30 | $1.33M 10-Q · filed 2023-11-13 | $2.63M derived: sum of 2 quarters · filed 2023-11-13 | $3.88M 10-Q · filed 2023-11-13 | $5.05M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-06-30 | $1.30M 10-Q · filed 2023-08-10 | $2.54M 10-Q · filed 2023-08-10 | $3.72M derived: sum of 3 quarters · filed 2024-05-10 | $4.75M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | $1.25M 10-Q · filed 2024-05-10 | $2.42M derived: sum of 2 quarters · filed 2024-05-10 | $3.45M derived: sum of 3 quarters · filed 2024-05-10 | $4.39M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $2.21M derived: sum of 2 quarters · filed 2024-03-22 | $3.14M derived: sum of 3 quarters · filed 2024-03-22 | $4.05M 10-K · filed 2024-03-22 |
| 2022-09-30 | $1.03M 10-Q · filed 2023-11-13 | $1.97M derived: sum of 2 quarters · filed 2023-11-13 | $2.88M 10-Q · filed 2023-11-13 | $3.80M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | $934.00K 10-Q · filed 2023-08-10 | $1.84M 10-Q · filed 2023-08-10 | $2.77M derived: sum of 3 quarters · filed 2024-03-22 | $3.69M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | $911.00K 10-Q · filed 2023-05-11 | $1.83M derived: sum of 2 quarters · filed 2024-03-22 | $2.75M derived: sum of 3 quarters · filed 2024-03-22 | $3.62M derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | $922.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $1.84M derived: sum of 2 quarters · filed 2024-03-22 | $2.71M derived: sum of 3 quarters · filed 2024-03-22 | $3.60M 10-K · filed 2024-03-22 |
| 2021-09-30 | $922.00K 10-Q · filed 2022-11-10 | $1.79M derived: sum of 2 quarters · filed 2022-11-10 | $2.67M 10-Q · filed 2022-11-10 | $3.58M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $864.00K 10-Q · filed 2022-08-11 | $1.75M 10-Q · filed 2022-08-11 | $2.66M derived: sum of 3 quarters · filed 2023-03-23 | $3.55M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | $889.00K 10-Q · filed 2022-05-11 | $1.79M derived: sum of 2 quarters · filed 2023-03-23 | $2.69M derived: sum of 3 quarters · filed 2023-03-23 | $3.57M derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | $903.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $1.80M derived: sum of 2 quarters · filed 2023-03-23 | $2.69M derived: sum of 3 quarters · filed 2023-03-23 | $3.56M 10-K · filed 2023-03-23 |
| 2020-09-30 | $898.00K 10-Q · filed 2021-11-12 | $1.78M derived: sum of 2 quarters · filed 2021-11-12 | $2.66M 10-Q · filed 2021-11-12 | $3.54M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | $884.00K 10-Q · filed 2021-08-12 | $1.76M 10-Q · filed 2021-08-12 | $2.65M derived: sum of 3 quarters · filed 2022-03-23 | $3.55M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-03-31 | $879.00K 10-Q · filed 2021-05-14 | $1.76M derived: sum of 2 quarters · filed 2022-03-23 | $2.66M derived: sum of 3 quarters · filed 2022-03-23 | $3.58M derived: sum of 4 quarters · filed 2022-03-23 |
| 2019-12-31 | $884.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $1.78M derived: sum of 2 quarters · filed 2022-03-23 | $2.70M derived: sum of 3 quarters · filed 2022-03-23 | $3.61M 10-K · filed 2022-03-23 |
| 2019-09-30 | $899.00K 10-Q · filed 2020-11-12 | $1.81M derived: sum of 2 quarters · filed 2020-11-12 | $2.73M 10-Q · filed 2020-11-12 | $3.49M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | $914.00K 10-Q · filed 2020-08-13 | $1.83M 10-Q · filed 2020-08-13 | $2.59M derived: sum of 3 quarters · filed 2021-03-25 | $2.90M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-03-31 | $912.00K 10-Q · filed 2020-05-15 | $1.68M derived: sum of 2 quarters · filed 2021-03-25 | $1.99M derived: sum of 3 quarters · filed 2021-03-25 | |
| 2018-12-31 | $765.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $1.07M derived: sum of 2 quarters · filed 2021-03-25 | $1.80M 10-K · filed 2021-03-25 | |
| 2018-09-30 | $309.00K 10-Q · filed 2019-12-18 | $1.04M 10-Q · filed 2019-12-18 | ||
| 2017-12-31 | $4.56M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |